This inventor holds 2 USPTO granted patents. Top assignees: University of Illinois, Leland Stanford Junior University. Active years: 1997-2014.
Location History:
- Champaign, IL (US) (1997)
- Mahomet, IL (US) (2014)
Company Filing History:
2 out of 2,420 
1 out of 5,492 
Years Active: 1997-2014
Title: Innovations by Timothy Alan Garrow
Introduction
Timothy Alan Garrow is an accomplished inventor based in Mahomet, IL (US). He holds 2 patents that focus on significant advancements in pharmaceutical compositions and methods aimed at reducing liver toxicity and managing homocysteine levels.
Latest Patents
One of his latest patents is titled "Compositions and methods for reducing the risk of agent-induced liver toxicity." This patent discusses pharmaceutical compositions that include acetaminophen and components such as S-adenosylhomocysteine (SAH) and S-methylmethionine (SMM). The methods outlined in this patent aim to reduce acetaminophen-induced liver toxicity in subjects.
Another notable patent is "Method of increasing the conversion of homocysteine to methionine." This invention provides a method for decreasing total plasma homocyst(e)ine levels in animals by administering a pharmacologically effective dose of a thetin. It also addresses the treatment of hyperhomocyst(e)inemia and offers novel pharmaceutical and nutritional compositions.
Career Highlights
Timothy has worked with prestigious institutions such as the University of Illinois and Leland Stanford Junior University. His contributions to the field of pharmaceuticals have been recognized for their potential impact on health and wellness.
Collaborations
Throughout his career, Timothy has collaborated with notable individuals, including Hong-Hsing Liu and Gary A Peltz. These partnerships have likely enriched his research and development efforts.
Conclusion
Timothy Alan Garrow's innovative work in pharmaceutical compositions and methods demonstrates his commitment to advancing medical science. His patents reflect a dedication to improving health outcomes and addressing critical health issues.